Payments for Royalties
What is the amount of cash paid by the company for royalties?
Filters
2022
Karyopharm Therapeutics Inc.
Massachusetts (United States)
29.3M
USD
2022
Aptevo Therapeutics Inc.
Washington (United States)
6.78M
USD
2022
Newlink Genetics Corp
Iowa (United States)
1M
USD
2022
Canfield Medical Supply Inc.
Florida (United States)
653,400
USD
2022
Desert Hawk Gold Corp.
Nevada (United States)
585,536
USD
2022
Atara Biotherapeutics Inc.
California (United States)
368,000
USD
2022
AngioSoma Inc
Washington (United States)
52,000
USD
2022
Athersys Inc
Ohio (United States)
0
USD
2022
Sevion Therapeutics Inc.
Massachusetts (United States)
0
USD
2021
Karyopharm Therapeutics Inc.
Massachusetts (United States)
10.4M
USD
2021
Aptevo Therapeutics Inc.
Washington (United States)
8.63M
USD
2021
Canfield Medical Supply Inc.
Florida (United States)
594,000
USD
2021
Desert Hawk Gold Corp.
Nevada (United States)
403,388
USD
2021
Newlink Genetics Corp
Iowa (United States)
146,000
USD
2021
Biosig Technologies Inc.
Connecticut (United States)
75,000
USD
2021
Bollente Companies Inc.
Arizona (United States)
25,000
USD
2021
Athersys Inc
Ohio (United States)
0
USD
2021
Sevion Therapeutics Inc.
Massachusetts (United States)
0
USD
2020
Zoom Video Communications, Inc
California (United States)
10.6M
USD
2020
Karyopharm Therapeutics Inc.
Massachusetts (United States)
6.01M
USD
attribution
Applying Attribution
Using this data requires appropriate attribution.